With advancements in understanding the tumor immune microenvironment (TIME), there is a growing emphasis on investigating the systemic anti-tumor immune responses, wherein dendritic cells (DCs) and CD8 T cells play pivotal roles7. The gene discussed is CD8A; the disease is neoplasm.